Show metadata Hide metadata

(19)

(11)

2 650 511

(13)

(51)

IPC

C07D403/04(2006-01-01)

C07D239/70(2006-01-01)

A61K31/517(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2014151016, 2013-05-17

(24)

Start date

2013-05-17

(22)

Actual filing date

2013-05-17

(45)

Published

2018-04-16

(72)

Inventor

Chakravarti ParomaKotkhari SandzhivGosselen FransisSevidzh Skott Dzh.Stalts Dzheffri

(73)

Holder

Dzhenentek, Ink.

FORMS AND COMPOSITION OF PYRIMIDINYL CYCLOPENTANE COMPOUNDS, COMPOSITIONS AND METHODS THEREOF Russian patent published in 2018 - IPC C07D403/04 C07D239/70 A61K31/517 A61P35/00

Abstract RU 2650511 C2

FIELD: medicine; pharmacology.

SUBSTANCE: invention relates to amorphous (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one monohydrochloride.

EFFECT: technical result: a new amorphous (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one monohydrochloride, as well as pharmaceutical formulations based on it, possessing AKT protein kinase inhibitory activity and can be used to treat cancer.

29 cl, 11 ex, 58 dwg, 6 tbl

Similar patents RU2650511C2

Title	Year	Author	Number
METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTAPYRIMIDINE COMPOUNDS AND THEIR SALTS	2013	Babu Srinivasan Gosselen Fransis Zhan Intsin Remarchuk Trevis Sevidzh Skott Dzh. Stalts Dzheffri Yadzhima Kherbert	RU2642311C2
BIOMARKERS FOR PREDICTION OF SENSITIVITY TO ANTITUMOR TREATMENT	2012	Lin, Kuj Punnus, Elizabet Seshagiri, Somasekar	RU2635193C2
HYDROXYLATED AND METHOXYLATED CYCLOPENTA[B]PYRIMIDINES AS PROTEIN KINASE INHIBITORS	2007	Mitchell Jan S. Blehjk Dzhejms F. Ksu Rui Kallan Nikolas K. Ksiao Dengming Spenser Kit Li Benksik Jozef R. Liang Dzun Safina Brajan Chzhang Birong Chabot Kristin Do Stiven Uolles Ilaj M. Behnka Anna L. Shlekhter Stiven T.	RU2478632C2
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND APPLICATION METHODS	2012	Nannini Mishel Sampatkh Dipak	RU2631240C2
CYCLOPENTA(D)PYRIMIDINES AS PROTEIN KINASE AKT INHIBITORS	2007	Mitchel Jan S. Blehjk Dzhejms F. Ksu Rui Kallan Nikolas K. Ksiao Dengming Spenser Kit Li Benksik Jozef R. Liang Dzun Safina Brajan Li Tszun Chabot Kristin Uolles Ilaj M. Banka Anna L. Shlekhter Stiven T.	RU2481336C2
HYDROXYLATED PYRIMIDYLCYCLOPENTANES AS PROTEIN KINASE (AKT) INHIBITORS	2009	Benksik Jozef R. Blehjk Dzhejms F. Kallan Nikolas K. Mitchell Jan S. Spenser Kit Li Ksiao Dengming Ksu Rui Chabot Kristin Do Stiven Liang Dzun Safina Brajan Chzhang Birong	RU2504542C2
METHOD OF PRODUCING PYRIMIDINYLCYCLOPENTANE COMPOUNDS	2014	Iding, Hans Reents, Reinhard Scalone, Michelangelo Gosselin, Francis	RU2826179C2
METHOD OF PRODUCING PYRIMIDINYLCYCLOPENTANE COMPOUNDS	2014	Iding Khans Reents Rajnkhard Skalone Mikelandzhelo Gosselen Fransis	RU2702355C1
HYDROXYLATED PYRIMIDYL CYCLOPENTANE AS PROTEINKINASE (ACT) INHIBITOR	2009	Benksik Jozef Blehjk Dzhejms F. Kallan Nikolas K. Mitchell Jan S. Spenser Kit L. Ksiao Dengming Ksu Rui Chabot Kristin Do Stiven Liang Dzun Safina Brajan Chzhang Birong	RU2520735C2
XIa FACTOR INHIBITORS	2016	Mertz, Eric Liu, Weiguo Edmondson, Scott, D. Ali, Amjad Gao, Ying-Duo Neelamkavil, Santhosh, F. So, Sung-Sau Moningka, Remond Sun, Wanying Hruza, Alan Brockunier, Linda, L.	RU2712268C2

RU 2 650 511 C2

Authors

Chakravarti Paroma

Kotkhari Sandzhiv

Gosselen Fransis

Sevidzh Skott Dzh.

Stalts Dzheffri

Dates

2018-04-16—Published

2013-05-17—Filed